
Deepa Belur
Examiner (ID: 2176, Phone: (571)270-3722 , Office: P/2472 )
| Most Active Art Unit | 2472 |
| Art Unit(s) | 2472 |
| Total Applications | 650 |
| Issued Applications | 513 |
| Pending Applications | 62 |
| Abandoned Applications | 96 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18769506
[patent_doc_number] => 20230364276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => One-Step Labeling of Antibodies to High Specific Activity with Actinium-225
[patent_app_type] => utility
[patent_app_number] => 18/305702
[patent_app_country] => US
[patent_app_date] => 2023-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7084
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18305702
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/305702 | One-Step Labeling of Antibodies to High Specific Activity with Actinium-225 | Apr 23, 2023 | Abandoned |
Array
(
[id] => 20547667
[patent_doc_number] => 12558440
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-24
[patent_title] => Radiopharmaceutical and methods
[patent_app_type] => utility
[patent_app_number] => 18/135595
[patent_app_country] => US
[patent_app_date] => 2023-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 7
[patent_no_of_words] => 11668
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 205
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18135595
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/135595 | Radiopharmaceutical and methods | Apr 16, 2023 | Issued |
Array
(
[id] => 18673170
[patent_doc_number] => 20230310663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => METHOD OF SYNTHESIZING 18F RADIOLABELED BIOMOLECULAR AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/301896
[patent_app_country] => US
[patent_app_date] => 2023-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9489
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18301896
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/301896 | METHOD OF SYNTHESIZING 18F RADIOLABELED BIOMOLECULAR AGENTS | Apr 16, 2023 | Pending |
Array
(
[id] => 18550832
[patent_doc_number] => 20230248832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => Small Molecule Ligand-Drug Conjugates for Targeted Cancer Therapy
[patent_app_type] => utility
[patent_app_number] => 18/123236
[patent_app_country] => US
[patent_app_date] => 2023-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10197
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18123236
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/123236 | Small Molecule Ligand-Drug Conjugates for Targeted Cancer Therapy | Mar 16, 2023 | Pending |
Array
(
[id] => 19479422
[patent_doc_number] => 20240327464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => PEPTIDE LIGAND TARGETING CARBONIC ANHYDRASE IX, PEPTIDE CONSTRUCT COMPRISING SAME, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/289027
[patent_app_country] => US
[patent_app_date] => 2023-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11207
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18289027
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/289027 | Peptide ligand targeting carbonic anhydrase IX, peptide construct comprising same, and uses thereof | Feb 9, 2023 | Issued |
Array
(
[id] => 19875882
[patent_doc_number] => 20250108139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-03
[patent_title] => PEPTIDE UREA DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING PEPTIDE UREA DERIVATIVE, AND APPLICATION OF PEPTIDE UREA DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 18/729913
[patent_app_country] => US
[patent_app_date] => 2023-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8286
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18729913
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/729913 | PEPTIDE UREA DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING PEPTIDE UREA DERIVATIVE, AND APPLICATION OF PEPTIDE UREA DERIVATIVE | Jan 29, 2023 | Pending |
Array
(
[id] => 18862021
[patent_doc_number] => 20230416457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => DUAL MODALITY UPS NANOPROBES FOR TUMOR ACIDOSIS IMAGING
[patent_app_type] => utility
[patent_app_number] => 18/159084
[patent_app_country] => US
[patent_app_date] => 2023-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18684
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18159084
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/159084 | DUAL MODALITY UPS NANOPROBES FOR TUMOR ACIDOSIS IMAGING | Jan 23, 2023 | Abandoned |
Array
(
[id] => 18467101
[patent_doc_number] => 20230201382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => RADIOLIGANDS FOR MYELIN
[patent_app_type] => utility
[patent_app_number] => 18/099924
[patent_app_country] => US
[patent_app_date] => 2023-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25819
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 212
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18099924
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/099924 | RADIOLIGANDS FOR MYELIN | Jan 20, 2023 | Abandoned |
Array
(
[id] => 18362731
[patent_doc_number] => 20230144322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => 18F-LABELED PSMA-TARGETED PET IMAGING AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/149981
[patent_app_country] => US
[patent_app_date] => 2023-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17665
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18149981
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/149981 | 18F-LABELED PSMA-TARGETED PET IMAGING AGENTS | Jan 3, 2023 | Abandoned |
Array
(
[id] => 18322713
[patent_doc_number] => 20230120841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => CASSETTE FOR STABILISED RADIOLABELLING REACTION
[patent_app_type] => utility
[patent_app_number] => 18/086075
[patent_app_country] => US
[patent_app_date] => 2022-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5244
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18086075
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/086075 | CASSETTE FOR STABILISED RADIOLABELLING REACTION | Dec 20, 2022 | Abandoned |
Array
(
[id] => 18656268
[patent_doc_number] => 20230302162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => RADIOLABELED DARAPLADIB AND ANALOGS THEREOF AND THEIR USE AS IMAGING COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/061715
[patent_app_country] => US
[patent_app_date] => 2022-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12283
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18061715
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/061715 | RADIOLABELED DARAPLADIB AND ANALOGS THEREOF AND THEIR USE AS IMAGING COMPOUNDS | Dec 4, 2022 | Abandoned |
Array
(
[id] => 18347949
[patent_doc_number] => 20230136060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => METHOD FOR PREPARING NANODIAMONDS LABELED WITH RADIOACTIVE GALLIUM
[patent_app_type] => utility
[patent_app_number] => 17/962614
[patent_app_country] => US
[patent_app_date] => 2022-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2610
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17962614
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/962614 | METHOD FOR PREPARING NANODIAMONDS LABELED WITH RADIOACTIVE GALLIUM | Oct 9, 2022 | Pending |
Array
(
[id] => 18229058
[patent_doc_number] => 20230068052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => ELUENT SOLUTION
[patent_app_type] => utility
[patent_app_number] => 17/962686
[patent_app_country] => US
[patent_app_date] => 2022-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4359
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17962686
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/962686 | ELUENT SOLUTION | Oct 9, 2022 | Abandoned |
Array
(
[id] => 19111346
[patent_doc_number] => 20240123096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => F-18 POSITRON DIAGNOSTIC CONTRAST AGENT PRECURSOR AND METHOD OF MANUFACTURING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/956326
[patent_app_country] => US
[patent_app_date] => 2022-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2252
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17956326
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/956326 | F-18 positron diagnostic contrast agent precursor and method of manufacturing the same | Sep 28, 2022 | Issued |
Array
(
[id] => 18282411
[patent_doc_number] => 20230097883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => ERGOTHIONEINE PET COMPOUNDS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/823707
[patent_app_country] => US
[patent_app_date] => 2022-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29791
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17823707
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/823707 | ERGOTHIONEINE PET COMPOUNDS AND METHODS OF USE THEREOF | Aug 30, 2022 | Pending |
Array
(
[id] => 19388003
[patent_doc_number] => 20240277873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => ULTRABRIGHT CHEMILUMINESCENT PROBES FOR DETECTION AND IMAGING
[patent_app_type] => utility
[patent_app_number] => 18/566471
[patent_app_country] => US
[patent_app_date] => 2022-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13736
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18566471
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/566471 | ULTRABRIGHT CHEMILUMINESCENT PROBES FOR DETECTION AND IMAGING | Aug 10, 2022 | Pending |
Array
(
[id] => 18056550
[patent_doc_number] => 20220387636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => PHARMACEUTICAL COMPOSITION CONTAINING 211AT-LABELED AMINO ACID DERIVATIVE, AND METHOD FOR PRODUCING SAID PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/882708
[patent_app_country] => US
[patent_app_date] => 2022-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7990
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17882708
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/882708 | PHARMACEUTICAL COMPOSITION CONTAINING 211AT-LABELED AMINO ACID DERIVATIVE, AND METHOD FOR PRODUCING SAID PHARMACEUTICAL COMPOSITION | Aug 7, 2022 | Abandoned |
Array
(
[id] => 18350679
[patent_doc_number] => 20230138790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => MULTIMODAL PET/MRI CONTRAST AGENT AND A PROCESS FOR THE SYNTHESIS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/879351
[patent_app_country] => US
[patent_app_date] => 2022-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15563
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17879351
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/879351 | MULTIMODAL PET/MRI CONTRAST AGENT AND A PROCESS FOR THE SYNTHESIS THEREOF | Aug 1, 2022 | Abandoned |
Array
(
[id] => 18434480
[patent_doc_number] => 20230181774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => Method, Apparatus, and System for Radiation Therapy
[patent_app_type] => utility
[patent_app_number] => 17/870973
[patent_app_country] => US
[patent_app_date] => 2022-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6074
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17870973
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/870973 | Method, Apparatus, and System for Radiation Therapy | Jul 21, 2022 | Abandoned |
Array
(
[id] => 18019152
[patent_doc_number] => 20220370651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => METHOD FOR PRODUCING Ac-225 SOLUTION AND METHOD FOR PRODUCING MEDICINE USING Ac-225 SOLUTION
[patent_app_type] => utility
[patent_app_number] => 17/869104
[patent_app_country] => US
[patent_app_date] => 2022-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12337
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 215
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17869104
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/869104 | Method for producing Ac-225 solution and method for producing medicine using Ac-225 solution | Jul 19, 2022 | Issued |